Ameriprise
CYTR

Ameriprise’s CytRx Corp CYTR Stock Holding History

Ameriprise’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-26
Closed – – 5252
2014
Q3 		$0 Sell
26
-16
-38% -$316 ﹤0.01% 6104
2014
Q2 		$1K Buy
42
+18
+75% +$410 ﹤0.01% 5491
2014
Q1 		$0 Hold
24
– – ﹤0.01% 5588
2013
Q4 		$1K Hold
24
– – ﹤0.01% 5081
2013
Q3 		$0 Hold
24
– – ﹤0.01% 5841
2013
Q2 		$0 Buy
+24
New +$354 ﹤0.01% 5656

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's CYTR Position: Q4 2014 in Review

Ameriprise sold out of CytRx Corp (CYTR) in Q4 2014, closing a stake of 26 shares.

Ameriprise first reported a position in CYTR in Q2 2013 and held it in 6 quarters. The position peaked at $1K in Q2 2014. 71 funds tracked by Wall St. Rank hold CYTR as of Q4 2014.

  • Ameriprise reported no remaining CytRx Corp position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 26 CytRx Corp shares in Q4 2014.
  • Ameriprise first reported a position in CytRx Corp in Q2 2013 and held it in 6 quarters.
  • Ameriprise's CytRx Corp position peaked at $1K in Q2 2014.
  • 71 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.